Safety and efficacy of active surveillance in patients with localized prostate cancer

被引：0
|
作者：
Mavuduru, Ravimohan [1 ]
Agarwal, Mayank Mohan [1 ]
Mandal, Arup K. [1 ]
机构：
[1] Nehru Hosp, Postgrad Inst Med Educ & Res, Adv Urol Ctr, Dept Urol, Level 2,B Block, Chandigarh 160012, India
来源：
INDIAN JOURNAL OF UROLOGY | 2008年 / 24卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：131 / +
页数：2
相关论文
共 50 条
  • [41] Patient Perspective on Watchful Waiting/Active Surveillance for Localized Prostate Cancer
    Xu, Jinping
    Neale, Anne Victoria
    Dailey, Rhonda K.
    Eggly, Susan
    Schwartz, Kendra L.
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2012, 25 (06) : 763 - 770
  • [42] Regional differences in the utilization of active surveillance in localized prostate cancer.
    Scherzer, Nickolas David
    Srivastav, Sudesh
    DiBiase, Steven J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [43] Active Surveillance: Treatment Modality that Expect Attention for Localized Prostate Cancer
    Ozkan, Tayyar Alp
    Dillioglugil, Ozdal
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2014, 13 (01): : 41 - 45
  • [44] Active surveillance for clinically localized prostate cancer--A systematic review
    Thomsen, Frederik B.
    Brasso, Klaus
    Klotz, Laurence H.
    Roder, M. Andreas
    Berg, Kasper D.
    Iversen, Peter
    JOURNAL OF SURGICAL ONCOLOGY, 2014, 109 (08) : 830 - 835
  • [45] FOCAL LASER ABLATION IN LOCALIZED PROSTATE CANCER: SAFETY AND EFFICACY
    Al-Hakeem, Yasser
    Raz, Orit
    Yilmaz, Helene
    Varol, Celi
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 60 - 61
  • [46] Active surveillance of localized prostate cancer.: Significance of prostate core needle biopsies
    Rueschoff, J.
    Middel, P.
    Albers, P.
    PATHOLOGE, 2008, 29 (05): : 339 - 347
  • [47] Evaluation and Active Treatment versus Active Surveillance of Localized Prostate Cancer in Renal Transplant Patients in the Era of Low and Very Low Risk Prostate Cancer
    Aminsharifi, Alireza
    Simon, Ross
    Polascik, Thomas J.
    Robertson, Cary N.
    Sudan, Debra L.
    Collins, Bradley H.
    Moul, Judd W.
    JOURNAL OF UROLOGY, 2019, 202 (03): : 469 - 474
  • [48] Defining the ideal patient for active surveillance in localized prostate cancer and the impact of active surveillance studies on clinical practice
    Dirim, Ayhan
    Ozkardes, Hakan
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2011, 10 (02): : 41 - 46
  • [49] Clinical Results for an Active Surveillance Cohort with Localized Prostate Cancer Receiving RT after Exiting Active Surveillance
    Torrente, S.
    Andreani, S.
    Badenchini, F.
    Rancati, T.
    Marenghi, C.
    Avuzzi, B.
    Morlino, S.
    Bedini, N.
    Villa, S.
    Chiorda, B. Noris
    Palorini, F.
    Andreoli, L.
    Di Florio, T.
    Catanzaro, M.
    Stagni, S.
    Biasoni, D.
    Torelli, T.
    Tesone, A.
    Nicolai, N.
    Valdagni, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E145 - E146
  • [50] Prostate-specific antigen doubling time as a progression criterion in an active surveillance programme for patients with localized prostate cancer
    Thomsen, Frederik Birkebaek
    Christensen, Ib Jarle
    Brasso, Klaus
    Roder, Martin Andreas
    Iversen, Peter
    BJU INTERNATIONAL, 2014, 113 (5B) : E98 - E105
12345